Wordt geladen…
Matrix Metalloproteinase 9/microRNA-145 Ratio: Bridging Genomic and Immunological Variabilities in Thyroid Cancer
Matrix metalloproteinase 9 (MMP9) and microRNA-145 (miR-145) have emerged as essential biomarkers in thyroid cancer progression and metastasis. However, their combined evaluation and clinical utility as a unified prognostic marker across diverse thyroid cancer subgroups remain unexplored. We investi...
Hoofdauteurs: | , , , , , , , |
---|---|
Formaat: | Online Artikel Texto |
Taal: | English |
Gepubliceerd in: |
MDPI
2023
|
Onderwerpen: | |
Online toegang: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669161/ https://www.ncbi.nlm.nih.gov/pubmed/38001954 http://dx.doi.org/10.3390/biomedicines11112953 |